The immoral gene: does it really exist?

Over the last years several European patents were opposed for protecting technology violating the morality requirement under Article 53(a) EPC. Attempts have been made by the Appeal Boards of the European Patent Office (EPO), as well as by amendments introduced into the Implementing Regulations of t...

Full description

Saved in:
Bibliographic Details
Published in:Science and engineering ethics 2005-01, Vol.11 (1), p.97-104
Main Authors: Zimmer, Franz-Josef, Sethmann, Svenja
Format: Article
Language:English
Subjects:
Bioethics
Biotechnology
Biotechnology - ethics
European Union
Humans
Inventions
Morality
Morals
Patents as Topic - ethics
Patents as Topic - legislation & jurisprudence
Stem cells
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Over the last years several European patents were opposed for protecting technology violating the morality requirement under Article 53(a) EPC. Attempts have been made by the Appeal Boards of the European Patent Office (EPO), as well as by amendments introduced into the Implementing Regulations of the European Patent Convention (EPC), to address this sensitive patentability requirement more precisely. The most recent hot topic coming up in this context is the patentability of stem cells. It is to be expected that this discussion will still go on in the field of biotechnological inventions for the next several years.
ISSN:1353-3452
1471-5546
DOI:10.1007/s11948-005-0061-9